Trademark: 85009184
Word
YANIKLER
Status
Dead
Status Code
710
Status Date
Friday, November 24, 2017
Serial Number
85009184
Registration Number
3947037
Registration Date
Tuesday, April 19, 2011
Mark Type
4000
Filing Date
Thursday, April 8, 2010
Published for Opposition
Tuesday, February 1, 2011
Cancellation Date
Friday, November 24, 2017

Trademark Owner History
MediGene AG - Original Registrant

Classifications
5 pharmaceutical and veterinary preparations, namely, medicines, vaccines, and serums for the testing, prevention, treatment and diagnosis of tumor precursors, benign and malignant tumors, in particular, warts, genital warts, neuronal tumors, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, crohn's disease, lupus erythematosus and multiple sclerosis, neurodegenerative disorders, in particular alzheimer's disease, huntington's disease, multiple sclerosis, parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or creutzfeldt-jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, bechterew's disease, fibromyalgia and lupus erythematodes, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and obesity, skin diseases, in particular warts, genital warts, bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections, and ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and retinoblastoma; all of the above consisting of low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, t-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration
The wording "YANIKLER" has no meaning in a foreign language.

Trademark Events
Nov 24, 2017
Cancelled Sec. 8 (6-Yr)
Apr 19, 2011
Registered-Principal Register
Feb 1, 2011
Official Gazette Publication Confirmation E-Mailed
Feb 1, 2011
Published For Opposition
Dec 29, 2010
Law Office Publication Review Completed
Dec 22, 2010
Approved For Pub - Principal Register
Dec 21, 2010
Teas/Email Correspondence Entered
Dec 21, 2010
Correspondence Received In Law Office
Dec 21, 2010
Assigned To Lie
Nov 29, 2010
Teas Response To Office Action Received
May 29, 2010
Notification Of Examiner's Amendment/Priority Action E-Mailed
May 29, 2010
Examiner's Amendment/Priority Action E-Mailed
May 29, 2010
Examiners Amendment And/Or Priority Action - Completed
May 27, 2010
Assigned To Examiner
Apr 13, 2010
New Application Office Supplied Data Entered In Tram
Apr 12, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24